Medtronic (MDT) Liabilities from Discontinued Operations (2017)

Medtronic (MDT) posted Liabilities from Discontinued Operations of 59000000.0 for Q3 2017, up 73.53% sequentially from 34000000.0 in Q2 2017.

Medtronic (MDT) Liabilities from Discontinued Operations (2017) Analysis & Trends

Medtronic has reported Liabilities from Discontinued Operations for 1 years, with the latest figure at 59000000.0 in Q3 2017.

Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 59000000.0 in Q3 2017, while the trailing twelve-month figure through Jul 2017 was 59000000.0 (changed N/A YoY) and the FY2017 annual result came in at 34000000.0, changed N/A from the prior year.
Liabilities from Discontinued Operations climbed to 59000000.0 in Q3 2017 per MDT's latest filing, from 34000000.0 in the prior quarter.
Over five years, Liabilities from Discontinued Operations peaked at 59000000.0 in Q3 2017 and troughed at 34000000.0 in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Zimmer Biomet Holdings	19.04 Bn	18.63 Bn	1.54 Bn

Download Data